May 22, 2024 2023 White Paper on Recent Issues in Bioanalysis: EU IVDR 2017/746 Implementation/Impact, IVD/CDx/CLIA Approved Assays, High Dimensional Cytometry, Multiplexing Technologies, LBA Tissue Analysis, Vaccine Study Endpoints, Cell-Based Assays for Biomarkers, Cell Therapy and Vaccines (PART 2 – Recommendations on Development & Validation of Biomarkers, IVD, CDx, Cell-Based, Flow Cytometry, Ligand-Binding and Enzyme Assays; Advanced Critical Reagents Strategies)
May 21, 2024 Before Translating Extracellular Vesicles into Personalized Diagnostics and Therapeutics: What We Could Do
May 16, 2024 Comparison of plasma and neuroimaging biomarkers to predict cognitive decline in non-demented memory clinic patients
May 8, 2024 Change from platform to high efficacy disease-modifying treatment for multiple sclerosis despite NEDA
April 24, 2024 Clinical value of plasma ALZpath pTau217 immunoassay for assessing mild cognitive impairment
April 24, 2024 Combined blood Neurofilament light chain and third ventricle width to differentiate Progressive Supranuclear Palsy from Parkinson’s Disease: A machine learning study
April 4, 2024 Plasma brain-derived tau is an amyloid-associated neurodegeneration biomarker in Alzheimer’s disease
April 3, 2024 High Frequency of Prior Severe Acute Respiratory Syndrome Coronavirus 2 Infection by Sensitive Nucleocapsid Assays